Immunological self/nonself discrimination

The hypothesis is presented that immunological integration of nonefficacious vs efficacious T cell antigen receptor (TCR) signals are foundational for self/nonself discrimination and that multiple integrative mechanisms are intrinsic to the molecular to molar organization of an adaptive immune response. These integrative mechanisms are proposed to adaptively regulate expression of costimulatory signals, such that foreign proteins are associated with the expression of costimulatory signals, whereas self-proteins are associated with the lack of costimulatory signaling. Overall, this model offers several unique contributions to the study of immunology. First, this model postulates that cognate TCR/major histocompatibility complex (MHC) interactions are sufficient to adaptively mediate immunological self/nonself discrimination. This model thereby offers a unique alternative to models that largely rely on innate immunity to prime immune discrimination. Second, the integrative model argues that the immune system can simultaneously reinforce self-tolerance and promote immunity to foreign organisms at the same time and in the same location. Many alternative models presume that pathogenic self-reactive T cells do not exist at the outset of an immune response against foreign agents. Third, the integrative model uniquely predicts relationships between immunodeficiency and autoimmune pathogenesis. Fourth, this model illustrates the regulatory advantages of cognate antigen presenting cell (APC) systems (i.e., T cell or B cell APC) compared to nonspecific APC. Cognate APC systems together with the respective clonotypic responders may comprise a fundamental “network” of lymphoid cells. Such networks would have clone-specific regulatory capabilities and may be central for immunological self/nonself discrimination. Fifth, this model provides an explanation for “infectious” tolerance without creating specialized subsets of “suppressor” or “regulatory” T cells. Each mature T cell retains the potential to reinforce tolerance or mediate immunity, depending on the specific antigenic cues present in the immediate environment.

[1]  P. Linsley,et al.  Regulation of self-tolerance by CD80/CD86 interactions. , 1997, Current opinion in immunology.

[2]  S. Tonegawa,et al.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice , 1993, Cell.

[3]  H. Wekerle,et al.  T cell receptor β chain usage in myelin basic protein‐specific rat T lymphocytes , 1989 .

[4]  D. Loh,et al.  Permissive recognition during positive selection , 1996, European journal of immunology.

[5]  R. Germain,et al.  Modified T-cell receptor ligands: moving beyond a strict occupancy model for T-cell activation by antigen. , 1995, Chemical immunology.

[6]  M. Bevan,et al.  The nature of the peptide/MHC ligand involved in positive selection. , 1996, Seminars in immunology.

[7]  M. de Carli,et al.  An update on human Th1 and Th2 cells. , 1997, International archives of allergy and immunology.

[8]  M. Loken,et al.  I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. , 1982, Journal of immunology.

[9]  I. Kalvakolanu,et al.  Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse , 1995, Journal of Neuroimmunology.

[10]  D A Peterson,et al.  Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Kurtzke Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[12]  R. Fenton,et al.  Danger versus tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytes. , 1997, Journal of the National Cancer Institute.

[13]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[14]  R. Noelle,et al.  The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells , 1998, Journal of leukocyte biology.

[15]  E. Washington,et al.  Role of the thymus in the generation of skin‐homing αβ and γδ virgin T cells , 1995, European journal of immunology.

[16]  A. Sher,et al.  In Vivo Microbial Stimulation Induces Rapid CD40 Ligand–independent Production of Interleukin 12 by Dendritic Cells and their Redistribution to T Cell Areas , 1997, The Journal of experimental medicine.

[17]  G. Prete The concept of type-1 and type-2 helper T cells and their cytokines in humans. , 1998 .

[18]  S. Cook,et al.  Evidence for multiple sclerosis as an infectious disease , 1995, Acta neurologica Scandinavica. Supplementum.

[19]  A. Weinberg,et al.  Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. , 1993, Journal of immunology.

[20]  Y. Wu,et al.  Identification of a costimulatory molecule rapidly induced by CD40L as CD44H , 1996, The Journal of experimental medicine.

[21]  M. Mannie,et al.  Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. , 1998, Cellular immunology.

[22]  T. Wyss-Coray,et al.  Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. , 1995, Cellular immunology.

[23]  A. Tomlinson,et al.  Identification of a naturally occurring ligand for thymic positive selection. , 1997, Immunity.

[24]  W. Heath,et al.  Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. , 1997, Cellular immunology.

[25]  L. Adorini,et al.  Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes. , 1997, Biochemical Society transactions.

[26]  C. Janeway,et al.  Thymic selection: two pathways to life and two to death. , 1994, Immunity.

[27]  Y. Wu,et al.  CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. , 1996, Journal of immunology.

[28]  R. Lechler,et al.  Mechanisms of peripheral T‐cell tolerance , 1997, Journal of viral hepatitis.

[29]  P. Allen,et al.  Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands. , 1998, Journal of immunology.

[30]  G. Freeman,et al.  Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.

[31]  D. Hafler,et al.  T cell anergy , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  P. Allen,et al.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.

[33]  T. Pozzan,et al.  Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation , 1987, The Journal of experimental medicine.

[34]  M. Mannie The post-activation refractory phase: a mechanism to measure antigenic complexity and ensure self-tolerance among mature peripheral T lymphocytes. , 1996, Medical hypotheses.

[35]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[36]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[37]  J. Gribben,et al.  B7-mediated costimulation and the immune response. , 1996, Blood reviews.

[38]  H. Grey,et al.  Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. , 1997, Journal of immunology.

[39]  M. Kaufman,et al.  Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. , 1991, International immunology.

[40]  T. Wyss-Coray,et al.  Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. , 1995, Journal of immunology.

[41]  P. Marrack,et al.  T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. , 1997, Immunity.

[42]  T. Honjo,et al.  Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjören's syndrome , 1996, European journal of immunology.

[43]  T. McConnell,et al.  Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage. , 1997, Cellular immunology.

[44]  J. Pieters,et al.  Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II‐restricted antigen presentation by electrophoresis , 1997, Electrophoresis.

[45]  G. Kroemer,et al.  Compartmentalization of the peripheral immune system. , 1993, Advances in immunology.

[46]  H. Grey,et al.  Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. , 1998, Journal of immunology.

[47]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[48]  B. Motyka,et al.  Influence of the affinity of selecting ligands on T cell positive and negative selection and the functional maturity of the positively selected T cells. , 1997, Critical reviews in immunology.

[49]  V. Schirrmacher,et al.  Expression of Ia antigens in a murine T-lymphoma variant. , 1985, Molecular immunology.

[50]  Y. Matsumoto,et al.  Preferential distribution of Vβ 8.2‐positive T cells in the central nervous system of rats with myelin basic protein‐induced autoimmune encephalomyelitis , 1993 .

[51]  M. Mannie,et al.  Partial agonism elicits an enduring phase of T-cell-medicated antigen presentation. , 1998, Cellular immunology.

[52]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.

[53]  H. Wekerle,et al.  Synthesis and cell surface display of class II determinants by long‐term propagated rat T line cells , 1987, European journal of immunology.

[54]  P. Finn,et al.  Fas modulation of apoptosis during negative selection of thymocytes. , 1996, Immunity.

[55]  A. Sharpe,et al.  The complexity of the B7-CD28/CTLA-4 costimulatory pathway. , 1998, Agents and actions. Supplements.

[56]  J. Sun,et al.  Limits to the differential avidity model of T cell selection in the thymus. , 1997, Journal of immunology.

[57]  C. Parish,et al.  Dependence of the adaptive immune response on innate immunity: Some questions answered but new paradoxes emerge , 1997, Immunology and cell biology.

[58]  C. Campagnoni,et al.  The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  H. Fujita,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[60]  A. Sharpe,et al.  Costimulation and autoimmunity. , 1996, Current opinion in immunology.

[61]  R. Flavell,et al.  The Role of CD40 Ligand in Costimulation and T‐Cell Activation , 1996, Immunological reviews.

[62]  A. Abbas,et al.  Homeostasis and self-tolerance in the immune system: turning lymphocytes off. , 1998, Science.

[63]  A. Lanzavecchia,et al.  A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low‐affinity ligands, but does not affect triggering by high‐affinity anti‐CD3 antibodies , 1997, European journal of immunology.

[64]  I. Lieberam,et al.  Peripheral tolerance of CD4 T cells following local activation in adolescent mice , 1996, European journal of immunology.

[65]  P. Allen,et al.  Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. , 1993, Journal of immunology.

[66]  M. D. Mannte Do holes in the T-cell repertoire have a center-surround regulatory structure? A rationale for the bifurcation of the Thl and Th2 pathways of differentiation , 1997 .

[67]  E. Sercarz,et al.  Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. , 1993, Journal of immunology.

[68]  H. Hartung,et al.  T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[69]  C. Coleclough,et al.  Repertoire of rat MBP-reactive T cells: DNA sequencing analysis further demonstrates the clonal heterogeneity of rat T cells reactive against encephalitogenic epitopes. , 1994, Cellular Immunology.

[70]  B. Pessac,et al.  Myelin Basic Protein‐Related Proteins in Mouse Brain and Immune Tissues , 1998, Journal of neurochemistry.

[71]  S. Sato,et al.  Occurrence of myelin-associated glycoprotein (MAG)-like immunoreactivity in some nervous, endocrine, and immune-related cells of the rat. An immunohistochemical study. , 1997, Molecular and chemical neuropathology.

[72]  M. Bevan,et al.  Specificity and flexibility in thymic selection , 1994, Nature.

[73]  M. Bevan,et al.  Positive selection of thymocytes. , 1995, Annual review of immunology.

[74]  Michael Loran Dustin,et al.  Making the T cell receptor go the distance: a topological view of T cell activation. , 1997, Immunity.

[75]  M. Mannie Immune discrimination of self and nonself: a unified theory for the induction of self tolerance among thymocytes and mature peripheral T cells. , 1993, Medical hypotheses.

[76]  C. Coleclough,et al.  Heterogeneity of rat encephalitogenic T cells elicited by variants of the myelin basic protein (68–86) peptide , 1995, European journal of immunology.

[77]  J. Shabanowitz,et al.  Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. , 1997, Immunity.

[78]  A. Sette,et al.  Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P. M. Chisholm,et al.  Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells. , 1986, Immunology.

[80]  T. Wyss-Coray,et al.  T cells as antigen-presenting cells. , 1994, Immunology today.

[81]  M. Bevan,et al.  T-cell selection. , 1998, Current opinion in immunology.

[82]  K. Lafferty,et al.  Pancreatic Islet Allograft Immunity and Tolerance: the Two‐Signal Hypothesis Revisited , 1996, Immunological reviews.

[83]  K. Lafferty,et al.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.

[84]  R. Winchester,et al.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization , 1980, The Journal of experimental medicine.

[85]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[86]  R. Swanborg,et al.  Characterization of brain‐isolated rat encephalitogenic T cell lines , 1994, European journal of immunology.

[87]  R. Germain,et al.  Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. , 1996, Seminars in immunology.

[88]  C. Bernard,et al.  Insights into the aetiology and pathogenesis of multiple sclerosis , 1998, Immunology and cell biology.

[89]  D. Abramowicz,et al.  The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. , 1995, International immunology.

[90]  E. Reinherz,et al.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression , 1979, The Journal of experimental medicine.

[91]  J. He,et al.  F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. , 1996, The Journal of clinical investigation.

[92]  M. Debenedette,et al.  Induction of costimulatory molecules B7-1 and B7-2 in murine B cells. the CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction. , 1996, Molecular immunology.

[93]  C. Janeway,et al.  Innate immunity: impact on the adaptive immune response. , 1997, Current opinion in immunology.

[94]  M. Marks Protein sorting within the mhc class II antigen-processing pathway , 1998, Immunologic research.

[95]  F. Andris,et al.  Induction of T cell unresponsiveness by anti‐CD3 antibodies occurs independently of co‐stimulatory functions , 1996, European journal of immunology.

[96]  M. Kaufman,et al.  A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. , 1996, International immunology.

[97]  C. Coleclough,et al.  Diverse T cell receptor β chain usage by rat encephalitogenic T cells reactive to residues 68‐88 of myelin basic protein , 1993, European journal of immunology.

[98]  J. Whitton,et al.  An overview of antigen presentation and its central role in the immune response. , 1998, Current topics in microbiology and immunology.

[99]  L. Hood,et al.  Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Germain,et al.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.

[101]  R. Winchester,et al.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.

[102]  C. Janeway,et al.  Immunological tolerance: Danger – pathogen on the premises! , 1996, Current Biology.

[103]  R. Germain,et al.  Partial signaling by CD8+ T cells in response to antagonist ligands , 1996, The Journal of experimental medicine.

[104]  A. Sette,et al.  A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. , 1994, Journal of immunology.

[105]  M. Jackson,et al.  Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells , 1997, The Journal of experimental medicine.

[106]  M. Mannie,et al.  Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. , 1995, Journal of immunology.

[107]  Y. Itoyama,et al.  Generation of CD4+ blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor molecules is required for the expression of potent encephalitogenicity. , 1989, Cellular immunology.

[108]  B. Fowlkes,et al.  Positive selection of T cells. , 1995, Current opinion in immunology.

[109]  C. Elson,et al.  Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.

[110]  S. Rodda,et al.  Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion , 1994, European journal of immunology.

[111]  B. Clarke Approaches to the development of novel inhibitors of hepatitis C virus replication , 1995, Journal of viral hepatitis.

[112]  J. Miller,et al.  Constitutive class I-restricted exogenous presentation of self antigens in vivo , 1996, The Journal of experimental medicine.

[113]  T. Olsson,et al.  Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[114]  H. Lassmann,et al.  The thymus and self-tolerance: co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus. , 1997, International immunology.

[115]  P. Klenerman,et al.  Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[116]  T. Hamaoka,et al.  Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2 , 1996, The Journal of experimental medicine.

[117]  C. Janeway,et al.  Requirement for CD40 Ligand in Costimulation Induction, T Cell Activation, and Experimental Allergic Encephalomyelitis , 1996, Science.

[118]  M. Mannie,et al.  Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen‐presenting cells , 1997, European journal of immunology.

[119]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[120]  T. Saibara,et al.  Binding of T cell receptor to major histocompatibility complex class II‐peptide complexes at the single‐cell level results in the induction of antigen unresponsiveness (anergy) , 1992, European journal of immunology.

[121]  N. Sarvetnick,et al.  Organ-specific autoimmunity. , 1997, Current opinion in immunology.

[122]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[123]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.

[124]  J. Matriano,et al.  L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. , 1991, Cellular immunology.

[125]  J. Lamb,et al.  Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction , 1984, Nature.

[126]  H. Grey,et al.  The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[127]  C. Campagnoni,et al.  Expression of the myelin proteolipid protein gene in the human fetal thymus , 1996, Journal of Neuroimmunology.

[128]  E. Washington,et al.  Virgin αβ and γδ T cells recirculate extensively through peripheral tissues and skin during normal development of the fetal immune system , 1995 .

[129]  E. Yunis,et al.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens , 1978, The Journal of experimental medicine.

[130]  H. Offner,et al.  Analysis of V beta 8-CDR3 sequences derived from central nervous system of Lewis rats with experimental autoimmune encephalomyelitis. , 1994, Journal of immunology.

[131]  R. Germain,et al.  T-cell signaling: The importance of receptor clustering , 1997, Current Biology.

[132]  H. Grey,et al.  The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. , 1993, Journal of immunology.

[133]  R. Germain,et al.  The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands , 1997, The Journal of experimental medicine.

[134]  J. Sprent,et al.  Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. , 1997, Immunity.

[135]  M. Mannie,et al.  Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. , 1996, Journal of immunology.

[136]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[137]  D. Hafler,et al.  T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen. , 1993, Journal of immunology.

[138]  James M. Wilson,et al.  CD40 Ligand-Dependent T Cell Activation: Requirement of B7-CD28 Signaling Through CD40 , 1996, Science.

[139]  M. Kaufman,et al.  T cell long‐term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction , 1994, European journal of immunology.

[140]  I. Cohen,et al.  Expression of major histocompatibility complex class II molecules in rat T cells , 1994, European journal of immunology.

[141]  B. Fowlkes,et al.  Selective events in T cell development. , 1994, Annual review of immunology.

[142]  M. Bevan,et al.  In thymic selection, peptide diversity gives and takes away. , 1997, Immunity.

[143]  H. Boehmer Thymic selection: a matter of life and death , 1992 .

[144]  G. Chelvanayagam,et al.  A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[145]  D. Allen,et al.  Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis , 1995, European journal of immunology.

[146]  E. Satyaraj,et al.  Induction of tolerance in freshly isolated alloreactive CD4+ T cells by activated T cell stimulators , 1994, European journal of immunology.

[147]  I. Horak Immunodeficiency in IL-2-knockout mice. , 1995, Clinical immunology and immunopathology.